1. Home
  2. VERA vs AFYA Comparison

VERA vs AFYA Comparison

Compare VERA & AFYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERA
  • AFYA
  • Stock Information
  • Founded
  • VERA 2016
  • AFYA 1999
  • Country
  • VERA United States
  • AFYA Brazil
  • Employees
  • VERA N/A
  • AFYA N/A
  • Industry
  • VERA Biotechnology: Pharmaceutical Preparations
  • AFYA Other Consumer Services
  • Sector
  • VERA Health Care
  • AFYA Real Estate
  • Exchange
  • VERA Nasdaq
  • AFYA Nasdaq
  • Market Cap
  • VERA 1.7B
  • AFYA 1.4B
  • IPO Year
  • VERA 2021
  • AFYA 2019
  • Fundamental
  • Price
  • VERA $29.16
  • AFYA $14.70
  • Analyst Decision
  • VERA Buy
  • AFYA Hold
  • Analyst Count
  • VERA 9
  • AFYA 5
  • Target Price
  • VERA $62.25
  • AFYA $18.10
  • AVG Volume (30 Days)
  • VERA 1.2M
  • AFYA 108.7K
  • Earning Date
  • VERA 11-07-2025
  • AFYA 11-12-2025
  • Dividend Yield
  • VERA N/A
  • AFYA 1.58%
  • EPS Growth
  • VERA N/A
  • AFYA 20.40
  • EPS
  • VERA N/A
  • AFYA 1.36
  • Revenue
  • VERA N/A
  • AFYA $650,778,153.00
  • Revenue This Year
  • VERA N/A
  • AFYA $14.67
  • Revenue Next Year
  • VERA N/A
  • AFYA $8.34
  • P/E Ratio
  • VERA N/A
  • AFYA $10.82
  • Revenue Growth
  • VERA N/A
  • AFYA 15.60
  • 52 Week Low
  • VERA $18.53
  • AFYA $13.47
  • 52 Week High
  • VERA $51.61
  • AFYA $19.90
  • Technical
  • Relative Strength Index (RSI)
  • VERA 53.54
  • AFYA 42.49
  • Support Level
  • VERA $29.50
  • AFYA $14.61
  • Resistance Level
  • VERA $32.17
  • AFYA $15.16
  • Average True Range (ATR)
  • VERA 1.34
  • AFYA 0.43
  • MACD
  • VERA -0.43
  • AFYA 0.01
  • Stochastic Oscillator
  • VERA 26.72
  • AFYA 43.94

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

About AFYA Afya Limited

Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergrad provides educational services through undergraduate courses related to medical school, undergraduate health science and other ex-health undergraduate programs, Continuing Education provides medical education, specialization and graduate courses in medicine, delivered through digital and in-person content; and Medical practice solution provides clinical decision, clinical management and doctor-patient relationships for physicians and provide access, demand and efficiency for the healthcare players.

Share on Social Networks: